Schedule 13G ownership disclosure
Keros Therapeutics Inc
Security class unavailable · CUSIP: 492327101
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-020377
- Form type
- SC 13G
- Filer
- Foresite Capital Fund IV, L.P.
- CIK
- CIK 1704131
- Filed
- Feb 11, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership